Multifunctional protein APPL2 contributes to survival of human glioma cells

Molecular Oncology

Volumn 7, Issue 1, 2013, Pages 67-84

  Pyrzynska, Beata ^a   Banach Orlowska, Magdalena ^a   Teperek Tkacz, Marta ^a   Miekus, Katarzyna ^b   Drabik, Grazyna ^b   Majka, Marcin ^b   Miaczynska, Marta ^a  

^a INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Apoptosis; APPL proteins; Endocytosis; GBM; Gene expression; HRK; NuRD; QPCR; RNAi; RTK; ShRNA; SiRNA; TCGA; Tumor cell biology

Indexed keywords

APPL2 PROTEIN; CELL PROTEIN; HARAKIRI PROTEIN; PROTEIN KINASE B; SMALL INTERFERING RNA; UNC5B PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL TRANSFORMATION; CELL VIABILITY; CELLULAR DISTRIBUTION; COLONY FORMATION; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVITY; GENE SILENCING; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 84872500686     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2012.08.003     Document Type: Article

References (55)

1. Banach-Orlowska M., Pilecka I., Torun A., Pyrzynska B., Miaczynska M. Functional characterization of the interactions between endosomal adaptor protein APPL1 and the NuRD co-repressor complex. Biochem. J. 2009, 423:389-400.
2. Brat D.J., Mapstone T.B. Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression. Ann. Intern. Med. 2003, 138:659-668.
3. Bredel M., Bredel C., Juric D., Harsh G.R., Vogel H., Recht L.D., Sikic B.I. Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res. 2005, 65:8679-8689.
4. Coultas L., Terzano S., Thomas T., Voss A., Reid K., Stanley E.G., Scott C.L., Bouillet P., Bartlett P., Ham J., Adams J.M., Strasser A. Hrk/DP5 contributes to the apoptosis of select neuronal populations but is dispensable for haematopoietic cell apoptosis. J. Cell. Sci. 2007, 120:2044-2052.
5. Delloye-Bourgeois C., Fitamant J., Paradisi A., Cappellen D., Douc-Rasy S., Raquin M.A., Stupack D., Nakagawara A., Rousseau R., Combaret V., Puisieux A., Valteau-Couanet D., Benard J., Bernet A., Mehlen P. Netrin-1 acts as a survival factor for aggressive neuroblastoma. J. Exp. Med. 2009, 206:833-847.
6. Dias J.A., Mahale S.D., Nechamen C.A., Davydenko O., Thomas R.M., Ulloa-Aguirre A. Emerging roles for the FSH receptor adapter protein APPL1 and overlap of a putative 14-3-3tau interaction domain with a canonical G-protein interaction site. Mol. Cell. Endocrinol. 2010, 329:17-25.
7. Fitamant J., Guenebeaud C., Coissieux M.M., Guix C., Treilleux I., Scoazec J.Y., Bachelot T., Bernet A., Mehlen P. Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proc. Natl. Acad. Sci. U S A 2008, 105:4850-4855.
8. Goldschneider D., Mehlen P. Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 2010, 29:1865-1882.
9. Guenebeaud C., Goldschneider D., Castets M., Guix C., Chazot G., Delloye-Bourgeois C., Eisenberg-Lerner A., Shohat G., Zhang M., Laudet V., Kimchi A., Bernet A., Mehlen P. The dependence receptor UNC5H2/B triggers apoptosis via PP2A-mediated dephosphorylation of DAP kinase. Mol. Cell. 2010, 40:863-876.
10. Haglund K., Rusten T.E., Stenmark H. Aberrant receptor signaling and trafficking as mechanisms in oncogenesis. Crit. Rev. Oncog. 2007, 13:39-74.
11. Harris C.A., Johnson E.M. BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J. Biol. Chem. 2001, 276:37754-37760.
12. He K., Jang S.W., Joshi J., Yoo M.H., Ye K. Akt-phosphorylated PIKE-A inhibits UNC5B-induced apoptosis in cancer cell lines in a p53-dependent manner. Mol. Biol. Cell. 2011, 22:1943-1954.
13. Hupalowska A., Pyrzynska B., Miaczynska M. APPL1 regulates basal NF-kappaB activity by stabilizing NIK. J. Cell. Sci. 2012, 10.1242/jcs.105171.
14. Husi H., Ward M.A., Choudhary J.S., Blackstock W.P., Grant S.G. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 2000, 3:661-669.
15. Imaizumi K., Morihara T., Mori Y., Katayama T., Tsuda M., Furuyama T., Wanaka A., Takeda M., Tohyama M. The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein. J. Biol. Chem. 1999, 274:7975-7981.
16. Inohara N., Ding L., Chen S., Nunez G. Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J. 1997, 16:1686-1694.
17. Jones R.B., Gordus A., Krall J.A., MacBeath G. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 2006, 439:168-174.
18. Krakstad C., Chekenya M. Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol. Cancer 2010, 9:135.
19. Lagger S., Meunier D., Mikula M., Brunmeir R., Schlederer M., Artaker M., Pusch O., Egger G., Hagelkruys A., Mikulits W., Weitzer G., Muellner E.W., Susani M., Kenner L., Seiser C. Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans. EMBO J. 2010, 29:3992-4007.
20. Lee J.R., Hahn H.S., Kim Y.H., Nguyen H.H., Yang J.M., Kang J.S., Hahn M.J. Adaptor protein containing PH domain, PTB domain and leucine zipper (APPL1) regulates the protein level of EGFR by modulating its trafficking. Biochem. Biophys. Res. Commun. 2011, 415:206-211.
21. Lin D.C., Quevedo C., Brewer N.E., Bell A., Testa J.R., Grimes M.L., Miller F.D., Kaplan D.R. APPL1 associates with TrkA and GIPC1 and is required for nerve growth factor-mediated signal transduction. Mol. Cell. Biol. 2006, 26:8928-8941.
22. Liu J., Yao F., Wu R., Morgan M., Thorburn A., Finley R.L., Chen Y.Q. Mediation of the DCC apoptotic signal by DIP13 alpha. J. Biol. Chem. 2002, 277:26281-26285.
23. Lytle R.A., Jiang Z., Zheng X., Higashikubo R., Rich K.M. Retinamide-induced apoptosis in glioblastomas is associated with down-regulation of Bcl-xL and Bcl-2 proteins. J. Neurooncol. 2005, 74:225-232.
24. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
25. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
26. Mao X., Kikani C.K., Riojas R.A., Langlais P., Wang L., Ramos F.J., Fang Q., Christ-Roberts C.Y., Hong J.Y., Kim R.Y., Liu F., Dong L.Q. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell. Biol. 2006, 8:516-523.
27. Mazelin L., Bernet A., Bonod-Bidaud C., Pays L., Arnaud S., Gespach C., Bredesen D.E., Scoazec J.Y., Mehlen P. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 2004, 431:80-84.
28. Miaczynska M., Christoforidis S., Giner A., Shevchenko A., Uttenweiler-Joseph S., Habermann B., Wilm M., Parton R.G., Zerial M. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 2004, 116:445-456.
29. Mitsuuchi Y., Johnson S.W., Sonoda G., Tanno S., Golemis E.A., Testa J.R. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene 1999, 18:4891-4898.
30. Mosesson Y., Mills G.B., Yarden Y. Derailed endocytosis: an emerging feature of cancer. Nat. Rev. Cancer 2008, 8:835-850.
31. Nechamen C.A., Thomas R.M., Cohen B.D., Acevedo G., Poulikakos P.I., Testa J.R., Dias J.A. Human follicle-stimulating hormone (FSH) receptor interacts with the adaptor protein APPL1 in HEK 293 cells: potential involvement of the PI3K pathway in FSH signaling. Biol. Reprod. 2004, 71:629-636.
32. Nechamen C.A., Thomas R.M., Dias J.A. APPL1, APPL2, Akt2 and FOXO1a interact with FSHR in a potential signaling complex. Mol. Cell. Endocrinol. 2007, 260-262:93-99.
33. Putcha G.V., Moulder K.L., Golden J.P., Bouillet P., Adams J.A., Strasser A., Johnson E.M. Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron 2001, 29:615-628.
34. Pyrzynska B., Pilecka I., Miaczynska M. Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis. Mol. Oncol. 2009, 3:321-338.
35. Rashid S., Pilecka I., Torun A., Olchowik M., Bielinska B., Miaczynska M. Endosomal adaptor proteins APPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription. J. Biol. Chem. 2009, 284:18115-18128.
36. Rizvi F., Heimann T., Herrnreiter A., O'Brien W.J. Mitochondrial dysfunction links ceramide activated HRK expression and cell death. PLoS One 2011, 6:e18137.
37. Saito T., Jones C.C., Huang S., Czech M.P., Pilch P.F. The interaction of Akt with APPL1 is required for insulin-stimulated Glut4 translocation. J. Biol. Chem. 2007, 282:32280-32287.
38. Sanz C., Benito A., Inohara N., Ekhterae D., Nunez G., Fernandez-Luna J.L. Specific and rapid induction of the proapoptotic protein Hrk after growth factor withdrawal in hematopoietic progenitor cells. Blood 2000, 95:2742-2747.
39. Sanz C., Mellstrom B., Link W.A., Naranjo J.R., Fernandez-Luna J.L. Interleukin 3-dependent activation of DREAM is involved in transcriptional silencing of the apoptotic Hrk gene in hematopoietic progenitor cells. EMBO J. 2001, 20:2286-2292.
40. Schenck A., Goto-Silva L., Collinet C., Rhinn M., Giner A., Habermann B., Brand M., Zerial M. The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell 2008, 133:486-497.
41. Sorkin A., von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell. Biol. 2009, 10:609-622.
42. Stommel J.M., Kimmelman A.C., Ying H., Nabioullin R., Ponugoti A.H., Wiedemeyer R., Stegh A.H., Bradner J.E., Ligon K.L., Brennan C., Chin L., DePinho R.A. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 2007, 318:287-290.
43. Sun L., Hui A.M., Su Q., Vortmeyer A., Kotliarov Y., Pastorino S., Passaniti A., Menon J., Walling J., Bailey R., Rosenblum M., Mikkelsen T., Fine H.A. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006, 9:287-300.
44. Tan Y., You H., Wu C., Altomare D.A., Testa J.R. Appl1 is dispensable for mouse development, and loss of Appl1 has growth factor-selective effects on Akt signaling in murine embryonic fibroblasts. J. Biol. Chem. 2010, 285:6377-6389.
45. Tanikawa C., Matsuda K., Fukuda S., Nakamura Y., Arakawa H. p53RDL1 regulates p53-dependent apoptosis. Nat. Cell. Biol. 2003, 5:216-223.
46. TCGA Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
47. Varsano T., Dong M.Q., Niesman I., Gacula H., Lou X., Ma T., Testa J.R., Yates J.R., Farquhar M.G. GIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signaling. Mol. Cell. Biol. 2006, 26:8942-8952.
48. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., Miller C.R., Ding L., Golub T., Mesirov J.P., Alexe G., Lawrence M., O'Kelly M., Tamayo P., Weir B.A., Gabriel S., Winckler W., Gupta S., Jakkula L., Feiler H.S., Hodgson J.G., James C.D., Sarkaria J.N., Brennan C., Kahn A., Spellman P.T., Wilson R.K., Speed T.P., Gray J.W., Meyerson M., Getz G., Perou C.M., Hayes D.N. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110.
49. Wakabayashi T., Kosaka J., Hommura S. Up-regulation of Hrk, a regulator of cell death, in retinal ganglion cells of axotomized rat retina. Neurosci. Lett. 2002, 318:77-80.
50. Wang R., Wei Z., Jin H., Wu H., Yu C., Wen W., Chan L.N., Wen Z., Zhang M. Autoinhibition of UNC5b revealed by the cytoplasmic domain structure of the receptor. Mol. Cell 2009, 33:692-703.
51. Weichert W. HDAC expression and clinical prognosis in human malignancies. Cancer Lett. 2009, 280:168-176.
52. Wen L., Yang Y., Wang Y., Xu A., Wu D., Chen Y. Appl1 is essential for the survival of Xenopus pancreas, duodenum, and stomach progenitor cells. Dev. Dyn. 2010, 239:2198-2207.
53. Yang L., Lin H.K., Altuwaijri S., Xie S., Wang L., Chang C. APPL suppresses androgen receptor transactivation via potentiating Akt activity. J. Biol. Chem. 2003, 278:16820-16827.
54. Zhu G., Chen J., Liu J., Brunzelle J.S., Huang B., Wakeham N., Terzyan S., Li X., Rao Z., Li G., Zhang X.C. Structure of the APPL1 BAR-PH domain and characterization of its interaction with Rab5. EMBO J. 2007, 26:3484-3493.
55. Zoncu R., Perera R.M., Balkin D.M., Pirruccello M., Toomre D., De Camilli P. A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell 2009, 136:1110-1121.